Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
USANA Health ( (USNA) ) has provided an announcement.
USANA Health Sciences reported an 11% increase in net sales for the second quarter of 2025 compared to the same period in 2024, despite a slight decline in net earnings. The company is maintaining its fiscal year 2025 outlook and continues to execute its growth strategy, including enhancements to its direct sales model and the launch of new products. Hiya, USANA’s direct-to-consumer business, performed well with strong year-over-year growth and a new partnership with Disney. The company also repurchased shares and ended the quarter with a strong cash position and no debt.
The most recent analyst rating on (USNA) stock is a Hold with a $65.00 price target. To see the full list of analyst forecasts on USANA Health stock, see the USNA Stock Forecast page.
Spark’s Take on USNA Stock
According to Spark, TipRanks’ AI Analyst, USNA is a Neutral.
USANA Health’s strong earnings call and reasonable valuation provide a positive outlook, but financial performance issues such as declining revenues and net profit margins weigh down the overall score. Technical indicators show mixed momentum, which contributes to a moderate overall stock score.
To see Spark’s full report on USNA stock, click here.
More about USANA Health
USANA Health Sciences, Inc. operates in the health and wellness industry, focusing on nutritional products and direct selling. The company emphasizes a comprehensive commercial strategy for its direct sales business and is expanding its direct-to-consumer business, Hiya, which recently launched a partnership with Disney.
Average Trading Volume: 169,627
Technical Sentiment Signal: Strong Sell
Current Market Cap: $565.2M
For an in-depth examination of USNA stock, go to TipRanks’ Overview page.